Wilmington, DE, United States of America

Laurine G Galya



 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 191(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Laurine G Galya: Innovator in Pharmaceutical Chemistry

Introduction

Laurine G Galya is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on various chemical derivatives. With a total of 3 patents, her research has the potential to impact drug development and therapeutic applications.

Latest Patents

Laurine's latest patents focus on hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. These inventions provide valuable insights into the chemical modifications that can enhance the efficacy and safety of pharmaceutical compounds. The detailed descriptions of her patents highlight the innovative approaches she has taken in her research.

Career Highlights

Throughout her career, Laurine has worked with notable companies such as Incyte Corporation and Incyte Holdings Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research initiatives.

Collaborations

Laurine has collaborated with talented individuals, including James David Rodgers and Adam Shilling. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions in pharmaceutical chemistry.

Conclusion

Laurine G Galya is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in drug development. Her contributions through her patents and collaborations reflect her commitment to innovation and excellence in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…